GSK launches OTC allergy relief spray – Flonase Sensimis Allergy Relief in US

GSK Consumer Healthcare has rolled out a new over-the-counter OTC allergy relief spray in the US under the brand name, Flonase Sensimis Allergy Relief which is fluticasone furoate, 27.5 mcg spray.

OTC Allergy Relief Spray – Flonase Sensimis Allergy Relief

The new GSK allergy nasal spray, Flonase Sensimis Allergy Relief gives relief from seasonal and perennial allergies. It can be bought online and also at big retail stores throughout the US.

Flonase Sensimis Allergy Relief, based on a novel MistPro technology, gives round the clock allergy relief by battling symptoms such as nasal congestion, running or itchy nose, sneezing, and itchy, watery eyes.

Jennifer Nadelson, Senior Brand Manager at Flonase on the new OTC allergy relief spray said: “GSK Consumer Healthcare has a strong heritage in discovering and developing respiratory products to meet patient needs worldwide.

“With FLONASE Sensimist, we’re proud to offer allergy sufferers an additional product option providing more complete symptom reliefi in a new, unique, user-friendly device.”

Flonase Sensimis Allergy Relief - GSK Allergy Nasal Spray.
Flonase Sensimis Allergy Relief – GSK Allergy Nasal Spray. Photo courtesy of GSK.

GSK Consumer Healthcare states that Flonase Sensimis Allergy Relief is a powerful mist spray that is non-drowsy, and can be sprayed daily into the nostrils.

How the New GSK Allergy Nasal Spray Works

The GSK allergy nasal spray from the consumer healthcare giant provides protection from allergies due to dust, pets, mold and pollen.

As per GSK Consumer Healthcare, Flonase Sensimis Allergy Relief inhibits six important inflammatory substances in contrast to a majority of OTC allergy pills which only work on allergy symptoms causing chemical, histamine.

Additionally, GSK Consumer Healthcare claims that its OTC allergy relief spray, Flonase Sensimist has been demonstrated to be 40% powerful than an unnamed leading non-drowsy allergy drug.

Dr. Clifford Bassett, Founder and Medical Director of Allergy & Asthma Care of New York talking about the new GSK allergy nasal spray said: “For the more than 50 million Americans who suffer from allergies, the burden is more than just a stuffy nose.

“Uncontrolled allergies have a measurable impact on quality of life, affecting children and adults. In my patient population, having a proactive treatment plan in place makes a big difference in managing their allergies.”

Other notable Flonase Sensimist features in terms of its novel ergonomic design are:

  • Alcohol-free
  • Delivers consistent dosing each time
  • Less invasive with the shortest nozzle
  • Little or no drip
  • Scent-free

Flonase Senior Brand Manager Jennifer Nadelson on the company’s new OTC allergy relief spray said: “GSK Consumer Healthcare has a strong heritage in discovering and developing respiratory products to meet patient needs worldwide.

“With Flonase Sensimist, we’re proud to offer allergy sufferers an additional product option providing more complete symptom reliefi in a new, unique, user-friendly device.”

The new GSK allergy nasal spray, Flonase Sensimist, which was earlier only a prescription medicine, secured its OTC availability from the US Food and Drug Administration (FDA) in August last year.

The OTC allergy nasal spray Sensimist is the third in the GSK Consumer Healthcare’s Flonase range which consists of Flonase Allergy Relief and Children’s Flonase Allergy Relief.

Leave a Reply

Your email address will not be published.